Form D · Other
VANTAGEPOINT HOLDINGS, INC.
New York, NY · CIK 0001526817
Offering snapshot reported Jun 28, 2016 · SEC filing
- Reported sold
- $1.1M Offering amount: $5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 14, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 28, 2016 | Initial | $1,100,000 | No comparison | 2 | SEC filing |
| May 19, 2016 | Initial | $6,776,721 | No comparison | 2 | SEC filing |
| Oct 20, 2015 | Initial | $5,479,974 | No comparison | 4 | SEC filing |
| Jul 24, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jul 24, 2013 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Jan 23, 2013 | Initial | $18,200,000 | No comparison | 4 | SEC filing |
| Jul 11, 2012 | Initial | $69,572,963 | No comparison | 4 | SEC filing |
| Mar 9, 2012 | Amendment | $12,770,000 | $7,500,000vs Aug 1, 2011 | 3 | SEC filing |
| Jan 23, 2012 | Amendment | $8,270,000 | $3,000,000vs Aug 1, 2011 | 3 | SEC filing |
| Aug 1, 2011 | Initial | $5,270,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-265884
The offering amount represents the sale and purchase of designated series preferred stock.
Source: Form D, filed Jun 28, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Theodore Bacon | Director |
| Ted Bacon | Director |
| Equity, Llc Cle | Director |
| N/A Cle Equity, Llc | Director |
| Randy G. Daniel | Director |
| Vikram Dashputre | Executive |
| Equity Fund Ii, L.P. Enhanced | Director |
| N/A Enhanced Equity Fund Ii, L.P. | Director |
| Brett A. Fliegler | Director, Executive |
| Patrick Furlong | Director, Executive |
| Michael Hanbury | Director, Executive |
| Malcolm T. Kostuchenko | Director |
| William Mc Donald | Director |
| David L. Morgan Ii | Director, Executive |
| Lee Ann H. Nichols | Director, Executive |
| Le Ann Nichols | Director, Executive |
| Richard Nicholson | Director |
| Brian Patchett | Executive |
| Thomas Schofield | Executive |
| Jonathan Schubert | Director |
| Brian Urban | Executive |
| Medical Laboratory, Llc West Pacific | Director |
| N/A West Pacific Medical Laboratory, Llc | Director |
| Vance R. White | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
601 Lexington Avenue 55 Th Floor
New York, NY, 10022
New York, NY, 10022